Citatuzumab (Anti-EpCAM / TROP1 / CD326)
Products
Description
Citatuzumab (Anti-EpCAM / TROP1 / CD326) is a recombinant immunotoxin that composed of humanized monoclonal antibody targeting EpCAM. It has antitumor activity and can be used in treatment of cancer. MW :145.4 KD.
Specifications
| Manufacturer Cat# | A2651 |
|---|